BSEInsider Trading / SAST7h ago · 25 Sept 2026, 11:43 am
Intimation of closure of trading window for the announcement of unaudited financial statment for the quarter and half year ended on September 30, 2026
Mercury Laboratories Ltd · 538964
✦ AI SummaryResults
Mercury Laboratories Ltd has announced the closure of its trading window for dealing in securities by Designated Persons and their relatives, effective from October 1, 2026, until 48 hours after the announcement of unaudited financial results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mercury Laboratories Ltd - 538964 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
8509ab29-cdf2-4050-91ac-71e8a021d2e0.pdf
View document text
Date: 25/09/2026
Corporate Relationship Department
BSE Limited
Phiroze Jeejeebhoy Tower, 25th Floor,
Dalal Street, Mumbai – 400 001
Scrip Code: 538964
Subject: Intimation regarding Closure of Trading Window
Dear Sir/Madam,
We hereby inform that pursuant to Securities and Exchange Board of India (Prohibition of Insider
Trading) (Amendment) Regulations, 2018 read with the SEBI (Prohibition of Insider Trading)
Regulations, 2015 as amended from time to time and as per Company’s Code of Conduct for
regulating, monitoring, reporting of trading by insiders, trading window for dealing in securities
of the Company by the Designated Persons and their relatives shall remain closed with effect from
Thursday, October 01, 2026. The trading window shall remain closed till 48 hours after the
announcement of the unaudited financial results of the Company for the quarter and half year
ended on September 30, 2026.
The date of the Board Meeting for considering the unaudited financial results for the quarter and
half year ended on September 30, 2026 will be intimated in due course
You are requested to take the above information on records.
Yours faithfully,
For Mercury Laboratories Limited
Krishna Shah
Company Secretary & Compliance Officer